Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally
Kodiak's Q1 Loss Wider Than Expected, Pipeline Development in Focus
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences
Kodiak Sciences (KOD) Up 2% Since Last Earnings Report: Can It Continue?
Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Kodiak Sciences: Road To $120
Kodiak Sciences (NASDAQ:KOD) Reaches New 52-Week High – Time to Buy?
KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate
Kodiak Sciences Stock Is Surging Friday: What's Driving The Action?
Kodiak Sciences shares surge after eye drug succeeds in late-stage study
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing
Kodiak Sciences Inc. (NASDAQ:KOD) Receives $28.29 Consensus Target Price from Brokerages
Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy
Kodiak Sciences (NASDAQ:KOD) Shares Down 5.9% – What’s Next?
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead
Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio
KOD Stock Up 24% in 3 Months: Here's What You Need to Know
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026
Kodiak Sciences Inc. (NASDAQ:KOD) Receives $26.57 Average PT from Brokerages
Kodiak Sciences Inc. (KOD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
Kodiak Sciences (NASDAQ:KOD) Shares Down 5.8% – What’s Next?
Kodiak Sciences (NASDAQ:KOD) Hits New 12-Month High – Here’s What Happened
Kodiak Sciences (NASDAQ:KOD) Shares Gap Up Following Insider Buying Activity
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025
Bros. Advisors Lp Baker Acquires 2,608,696 Shares of Kodiak Sciences (NASDAQ:KOD) Stock
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock
Kodiak Sciences Announces Proposed Public Offering of Common Stock
Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results
Kodiak Sciences to Present at Upcoming Investor Conferences
Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI)
The Big 3: GOOGL, KOD, FTK
New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)
Why Is Kodiak Sciences (KOD) Down 1.2% Since Last Earnings Report?
Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI)
Harbour BioMed Reports 2025 Interim Results
Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock
Kodiak Sciences to Present at American Chemical Society Fall 2025
Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus
Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results
Kodiak Sciences to Host Investor R&D Day on July 16, 2025
Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society
Why Is Kodiak Sciences (KOD) Up 10.5% Since Last Earnings Report?
Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference
Kodiak Q1 Loss Wider Than Expected, Pipeline Development in Focus